Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus
US5733781A · kind A · utility
7Cited by
9References
104Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 1994 |
| Grant date | Mar 31, 1998 |
| Priority date | — |
| Expiry date | Jul 19, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns the use of oligonucleotides to inhibit propagation of human immunodeficiency virus (HIV). Preferred HIV target sites are identified and oligonucleotides designed to hybridize to a target site, or be analogous to a target site, are described. The preferred use of the oligonucleotides is to inhibit HIV propagation in a patient infected with HIV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.